Concepts (348)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 34 | 2023 | 938 | 10.720 |
Why?
|
| Apolipoprotein E4 | 14 | 2023 | 227 | 4.830 |
Why?
|
| Alzheimer Disease | 18 | 2023 | 1942 | 4.050 |
Why?
|
| Cognition | 26 | 2023 | 1277 | 2.840 |
Why?
|
| Aged | 68 | 2023 | 9448 | 2.780 |
Why?
|
| Cognition Disorders | 13 | 2018 | 1011 | 2.710 |
Why?
|
| Stroke | 6 | 2023 | 293 | 2.660 |
Why?
|
| Female | 73 | 2023 | 16197 | 2.110 |
Why?
|
| Apolipoproteins E | 8 | 2023 | 230 | 2.010 |
Why?
|
| Humans | 90 | 2023 | 29337 | 2.000 |
Why?
|
| Male | 63 | 2023 | 15621 | 1.970 |
Why?
|
| Longitudinal Studies | 22 | 2022 | 1442 | 1.700 |
Why?
|
| Activities of Daily Living | 8 | 2018 | 501 | 1.700 |
Why?
|
| Exercise | 9 | 2023 | 468 | 1.660 |
Why?
|
| Cohort Studies | 19 | 2023 | 1939 | 1.660 |
Why?
|
| White Matter | 3 | 2022 | 149 | 1.630 |
Why?
|
| Aging | 10 | 2023 | 1593 | 1.610 |
Why?
|
| Biomarkers | 8 | 2023 | 689 | 1.570 |
Why?
|
| Population Surveillance | 3 | 2021 | 116 | 1.540 |
Why?
|
| Chicago | 19 | 2022 | 865 | 1.440 |
Why?
|
| Risk Factors | 20 | 2023 | 2443 | 1.410 |
Why?
|
| Vitamin E | 2 | 2023 | 27 | 1.380 |
Why?
|
| Intermediate Filaments | 4 | 2023 | 17 | 1.360 |
Why?
|
| Aged, 80 and over | 29 | 2022 | 4851 | 1.340 |
Why?
|
| Dementia | 8 | 2022 | 521 | 1.260 |
Why?
|
| Mortality | 4 | 2021 | 86 | 1.140 |
Why?
|
| tau Proteins | 3 | 2023 | 202 | 1.130 |
Why?
|
| Disease Progression | 9 | 2019 | 787 | 1.070 |
Why?
|
| Genotype | 6 | 2018 | 405 | 1.060 |
Why?
|
| Alleles | 8 | 2023 | 224 | 1.060 |
Why?
|
| Whole Grains | 1 | 2023 | 3 | 0.970 |
Why?
|
| Prospective Studies | 11 | 2023 | 1811 | 0.960 |
Why?
|
| Disability Evaluation | 4 | 2014 | 327 | 0.940 |
Why?
|
| Neuropathology | 3 | 2021 | 79 | 0.900 |
Why?
|
| Vitamin D | 1 | 2022 | 31 | 0.860 |
Why?
|
| Incidence | 10 | 2023 | 756 | 0.840 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 117 | 0.810 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 85 | 0.810 |
Why?
|
| Healthy Lifestyle | 4 | 2022 | 28 | 0.800 |
Why?
|
| Depression | 3 | 2014 | 465 | 0.790 |
Why?
|
| United States | 11 | 2023 | 2333 | 0.780 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 6 | 0.780 |
Why?
|
| Blood Pressure | 2 | 2021 | 238 | 0.780 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 31 | 0.770 |
Why?
|
| Membrane Proteins | 1 | 2021 | 173 | 0.740 |
Why?
|
| Geriatric Assessment | 4 | 2021 | 219 | 0.690 |
Why?
|
| Diet | 4 | 2023 | 174 | 0.650 |
Why?
|
| Neuropsychological Tests | 11 | 2018 | 1251 | 0.640 |
Why?
|
| Art | 1 | 2016 | 3 | 0.600 |
Why?
|
| Music | 1 | 2016 | 19 | 0.580 |
Why?
|
| Time Factors | 8 | 2021 | 1616 | 0.580 |
Why?
|
| Mental Status and Dementia Tests | 3 | 2023 | 80 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 441 | 0.570 |
Why?
|
| Diabetes Complications | 1 | 2016 | 64 | 0.570 |
Why?
|
| Models, Statistical | 2 | 2021 | 132 | 0.560 |
Why?
|
| Life Style | 5 | 2022 | 211 | 0.540 |
Why?
|
| Obesity | 6 | 2014 | 291 | 0.530 |
Why?
|
| Prevalence | 3 | 2023 | 487 | 0.530 |
Why?
|
| Cognitive Aging | 4 | 2021 | 81 | 0.520 |
Why?
|
| Body Mass Index | 6 | 2018 | 428 | 0.510 |
Why?
|
| Depressive Disorder | 1 | 2015 | 187 | 0.500 |
Why?
|
| Mobility Limitation | 1 | 2015 | 97 | 0.500 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 18 | 0.490 |
Why?
|
| Follow-Up Studies | 9 | 2018 | 1830 | 0.480 |
Why?
|
| Memantine | 1 | 2014 | 13 | 0.480 |
Why?
|
| Dopamine Agents | 1 | 2014 | 40 | 0.480 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 200 | 0.470 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 301 | 0.470 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 306 | 0.470 |
Why?
|
| Antioxidants | 1 | 2014 | 56 | 0.470 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 402 | 0.460 |
Why?
|
| Health Status Disparities | 1 | 2013 | 69 | 0.450 |
Why?
|
| Memory, Episodic | 3 | 2018 | 116 | 0.430 |
Why?
|
| Motor Activity | 1 | 2015 | 369 | 0.430 |
Why?
|
| Diagnosis | 1 | 2011 | 23 | 0.420 |
Why?
|
| Medical Informatics | 1 | 2011 | 9 | 0.420 |
Why?
|
| Area Under Curve | 1 | 2011 | 66 | 0.420 |
Why?
|
| Linear Models | 3 | 2016 | 254 | 0.390 |
Why?
|
| Refusal to Participate | 1 | 2010 | 2 | 0.390 |
Why?
|
| Independent Living | 3 | 2022 | 281 | 0.380 |
Why?
|
| Disabled Persons | 1 | 2012 | 127 | 0.380 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 521 | 0.350 |
Why?
|
| Age of Onset | 3 | 2014 | 108 | 0.340 |
Why?
|
| Genetic Loci | 3 | 2018 | 61 | 0.330 |
Why?
|
| Postmenopause | 7 | 2006 | 61 | 0.310 |
Why?
|
| Middle Aged | 20 | 2019 | 9823 | 0.300 |
Why?
|
| Memory Disorders | 2 | 2018 | 174 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 1221 | 0.280 |
Why?
|
| Neuroticism | 2 | 2023 | 33 | 0.270 |
Why?
|
| Survivors | 3 | 2022 | 57 | 0.260 |
Why?
|
| Hypoglycemic Agents | 2 | 2016 | 56 | 0.260 |
Why?
|
| Diet, Mediterranean | 2 | 2022 | 62 | 0.250 |
Why?
|
| Florida | 1 | 2023 | 20 | 0.240 |
Why?
|
| Sex Factors | 2 | 2022 | 496 | 0.230 |
Why?
|
| Tocopherols | 1 | 2023 | 6 | 0.230 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 9 | 0.230 |
Why?
|
| Flavonols | 1 | 2022 | 6 | 0.230 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 3 | 0.230 |
Why?
|
| Vitamins | 1 | 2022 | 17 | 0.220 |
Why?
|
| Regression Analysis | 4 | 2011 | 298 | 0.220 |
Why?
|
| Loneliness | 1 | 2023 | 52 | 0.220 |
Why?
|
| Brain Infarction | 1 | 2023 | 74 | 0.220 |
Why?
|
| Life Expectancy | 1 | 2022 | 19 | 0.220 |
Why?
|
| Dietary Supplements | 1 | 2022 | 53 | 0.220 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2022 | 20 | 0.210 |
Why?
|
| Adult | 10 | 2023 | 8601 | 0.210 |
Why?
|
| Cognitive Reserve | 1 | 2022 | 37 | 0.210 |
Why?
|
| Age Factors | 2 | 2022 | 843 | 0.210 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 7 | 0.200 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 43 | 0.200 |
Why?
|
| Cost of Illness | 1 | 2021 | 54 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 294 | 0.190 |
Why?
|
| Noise | 1 | 2020 | 24 | 0.190 |
Why?
|
| Early Diagnosis | 1 | 2020 | 65 | 0.190 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 113 | 0.180 |
Why?
|
| Neuroimaging | 1 | 2020 | 136 | 0.180 |
Why?
|
| Confidence Intervals | 2 | 2017 | 96 | 0.170 |
Why?
|
| Phototherapy | 1 | 2019 | 37 | 0.170 |
Why?
|
| Residence Characteristics | 1 | 2020 | 216 | 0.170 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 14 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 195 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 217 | 0.170 |
Why?
|
| Social Networking | 1 | 2018 | 10 | 0.170 |
Why?
|
| Healthy Aging | 1 | 2018 | 14 | 0.160 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 23 | 0.160 |
Why?
|
| Behavioral Symptoms | 1 | 2018 | 13 | 0.160 |
Why?
|
| Interviews as Topic | 2 | 2016 | 130 | 0.160 |
Why?
|
| Hippocampus | 1 | 2020 | 274 | 0.160 |
Why?
|
| Nursing Homes | 1 | 2018 | 38 | 0.160 |
Why?
|
| Odds Ratio | 2 | 2017 | 285 | 0.160 |
Why?
|
| Iodide Peroxidase | 1 | 2018 | 34 | 0.160 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 328 | 0.160 |
Why?
|
| Brain | 3 | 2022 | 1689 | 0.160 |
Why?
|
| Social Environment | 1 | 2018 | 79 | 0.160 |
Why?
|
| Defecation | 1 | 2017 | 3 | 0.150 |
Why?
|
| Starch | 1 | 2017 | 7 | 0.150 |
Why?
|
| Low Back Pain | 1 | 2019 | 139 | 0.150 |
Why?
|
| Pain Management | 1 | 2019 | 143 | 0.150 |
Why?
|
| Prebiotics | 1 | 2017 | 16 | 0.150 |
Why?
|
| Microspheres | 1 | 2017 | 32 | 0.150 |
Why?
|
| Dietary Fiber | 1 | 2017 | 22 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 86 | 0.150 |
Why?
|
| Invasive Fungal Infections | 1 | 2017 | 4 | 0.150 |
Why?
|
| Frozen Sections | 1 | 2017 | 11 | 0.150 |
Why?
|
| Aspergillosis | 1 | 2017 | 10 | 0.150 |
Why?
|
| Mucormycosis | 1 | 2017 | 8 | 0.150 |
Why?
|
| Birth Order | 1 | 2016 | 2 | 0.150 |
Why?
|
| Parity | 1 | 2016 | 4 | 0.150 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 3 | 0.150 |
Why?
|
| Reproduction | 1 | 2016 | 12 | 0.150 |
Why?
|
| Warfare | 1 | 2016 | 14 | 0.150 |
Why?
|
| Terrorism | 1 | 2016 | 13 | 0.150 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 61 | 0.150 |
Why?
|
| Inflammation | 1 | 2018 | 344 | 0.140 |
Why?
|
| Reading | 1 | 2016 | 40 | 0.140 |
Why?
|
| Clinical Competence | 2 | 2015 | 230 | 0.140 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 8 | 0.140 |
Why?
|
| Overweight | 2 | 2014 | 65 | 0.130 |
Why?
|
| Self Report | 1 | 2016 | 218 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2016 | 1184 | 0.130 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 8 | 0.130 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 12 | 0.130 |
Why?
|
| Urinalysis | 1 | 2015 | 9 | 0.130 |
Why?
|
| Carbohydrates | 1 | 2015 | 14 | 0.130 |
Why?
|
| Adipose Tissue | 3 | 2005 | 73 | 0.130 |
Why?
|
| Models, Genetic | 1 | 2015 | 35 | 0.130 |
Why?
|
| Parkinson Disease | 2 | 2022 | 1164 | 0.130 |
Why?
|
| Insulin | 2 | 2014 | 92 | 0.130 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 168 | 0.130 |
Why?
|
| Educational Measurement | 1 | 2015 | 59 | 0.130 |
Why?
|
| Blood Glucose | 2 | 2014 | 112 | 0.130 |
Why?
|
| Demography | 1 | 2014 | 77 | 0.130 |
Why?
|
| Rhinitis | 1 | 2017 | 165 | 0.120 |
Why?
|
| Intelligence Tests | 1 | 2014 | 15 | 0.120 |
Why?
|
| Interview, Psychological | 1 | 2014 | 36 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2014 | 14 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 189 | 0.120 |
Why?
|
| Hospitalization | 2 | 2014 | 317 | 0.120 |
Why?
|
| Cats | 1 | 2014 | 76 | 0.120 |
Why?
|
| Sinusitis | 1 | 2017 | 187 | 0.120 |
Why?
|
| Models, Psychological | 1 | 2014 | 67 | 0.120 |
Why?
|
| Medicare | 1 | 2014 | 121 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 340 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2015 | 226 | 0.120 |
Why?
|
| Colonoscopy | 1 | 2013 | 51 | 0.110 |
Why?
|
| Emergency Medicine | 1 | 2015 | 79 | 0.110 |
Why?
|
| Adenoma | 1 | 2013 | 42 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 220 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 343 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2014 | 330 | 0.110 |
Why?
|
| Urban Population | 1 | 2013 | 143 | 0.110 |
Why?
|
| Social Support | 1 | 2014 | 185 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 138 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 82 | 0.110 |
Why?
|
| Health Status | 1 | 2014 | 227 | 0.110 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 329 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 75 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2011 | 48 | 0.100 |
Why?
|
| ROC Curve | 1 | 2011 | 138 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2013 | 246 | 0.100 |
Why?
|
| Gait | 1 | 2015 | 404 | 0.100 |
Why?
|
| Elder Abuse | 1 | 2011 | 34 | 0.100 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 168 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 106 | 0.100 |
Why?
|
| Testosterone | 3 | 2004 | 32 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2010 | 218 | 0.090 |
Why?
|
| Algorithms | 1 | 2010 | 400 | 0.080 |
Why?
|
| Common Cold | 1 | 2006 | 5 | 0.070 |
Why?
|
| Young Adult | 3 | 2018 | 1932 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2019 | 394 | 0.070 |
Why?
|
| Smoking Prevention | 1 | 2005 | 17 | 0.070 |
Why?
|
| Phenotype | 2 | 2016 | 355 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 33 | 0.070 |
Why?
|
| Observer Variation | 2 | 2015 | 118 | 0.070 |
Why?
|
| Peptide Hormones | 1 | 2004 | 3 | 0.070 |
Why?
|
| Diet, Reducing | 1 | 2004 | 11 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2005 | 50 | 0.060 |
Why?
|
| Animals | 1 | 2014 | 4552 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 97 | 0.060 |
Why?
|
| Androgens | 1 | 2004 | 8 | 0.060 |
Why?
|
| Sulfotransferases | 1 | 2004 | 6 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 6 | 0.060 |
Why?
|
| Estrogens | 1 | 2004 | 33 | 0.060 |
Why?
|
| Parents | 1 | 2005 | 105 | 0.060 |
Why?
|
| Metabolic Syndrome | 1 | 2005 | 66 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 216 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 553 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 10 | 0.060 |
Why?
|
| Quercetin | 1 | 2022 | 7 | 0.060 |
Why?
|
| Kaempferols | 1 | 2022 | 7 | 0.060 |
Why?
|
| Eating | 1 | 2022 | 45 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 959 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2022 | 12 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 102 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2021 | 19 | 0.050 |
Why?
|
| Washington | 3 | 2006 | 5 | 0.050 |
Why?
|
| Logistic Models | 2 | 2013 | 407 | 0.050 |
Why?
|
| Atrophy | 1 | 2021 | 102 | 0.050 |
Why?
|
| Tremor | 1 | 2022 | 141 | 0.050 |
Why?
|
| Autopsy | 1 | 2021 | 335 | 0.050 |
Why?
|
| Smoking | 2 | 2015 | 194 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 78 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2019 | 20 | 0.040 |
Why?
|
| Child | 2 | 2018 | 1346 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 34 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 7 | 0.040 |
Why?
|
| Hypertension | 1 | 2021 | 266 | 0.040 |
Why?
|
| Neurotic Disorders | 1 | 2018 | 19 | 0.040 |
Why?
|
| Threonine | 1 | 2018 | 7 | 0.040 |
Why?
|
| Alanine | 1 | 2018 | 9 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 26 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 37 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2018 | 75 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 21 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2018 | 77 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 125 | 0.040 |
Why?
|
| Veterans | 1 | 2019 | 63 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 127 | 0.040 |
Why?
|
| Chronic Pain | 1 | 2019 | 112 | 0.040 |
Why?
|
| Fermentation | 1 | 2017 | 12 | 0.040 |
Why?
|
| Constipation | 1 | 2017 | 21 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 2279 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 30 | 0.040 |
Why?
|
| Mucor | 1 | 2017 | 4 | 0.040 |
Why?
|
| Aspergillus | 1 | 2017 | 7 | 0.040 |
Why?
|
| Educational Status | 1 | 2018 | 295 | 0.040 |
Why?
|
| Nasal Surgical Procedures | 1 | 2017 | 8 | 0.040 |
Why?
|
| Liver | 1 | 2018 | 173 | 0.040 |
Why?
|
| Maternal Age | 1 | 2016 | 15 | 0.040 |
Why?
|
| Feces | 1 | 2017 | 98 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 12 | 0.040 |
Why?
|
| Fertility | 1 | 2016 | 20 | 0.040 |
Why?
|
| Russia | 1 | 2016 | 3 | 0.040 |
Why?
|
| Jews | 1 | 2016 | 4 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 55 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 45 | 0.040 |
Why?
|
| Israel | 1 | 2016 | 16 | 0.040 |
Why?
|
| Emigration and Immigration | 1 | 2016 | 13 | 0.040 |
Why?
|
| Arabs | 1 | 2016 | 7 | 0.040 |
Why?
|
| Nose | 1 | 2017 | 36 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 48 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 638 | 0.040 |
Why?
|
| Acute Disease | 1 | 2017 | 226 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2017 | 503 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 313 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 280 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 17 | 0.030 |
Why?
|
| Gallbladder | 1 | 2015 | 5 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 7 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 403 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 7 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 44 | 0.030 |
Why?
|
| Endoscopy | 1 | 2017 | 181 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 40 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 21 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 41 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 46 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 42 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 220 | 0.030 |
Why?
|
| China | 1 | 2014 | 59 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 134 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3273 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 225 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 180 | 0.030 |
Why?
|
| Body Weight | 2 | 2004 | 133 | 0.030 |
Why?
|
| Estrone | 2 | 2004 | 6 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 53 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2004 | 15 | 0.030 |
Why?
|
| Estradiol | 2 | 2004 | 58 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 132 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 49 | 0.030 |
Why?
|
| Patient Compliance | 2 | 2005 | 164 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 678 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 145 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 668 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 79 | 0.030 |
Why?
|
| Critical Illness | 1 | 2014 | 123 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 5 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 699 | 0.030 |
Why?
|
| Length of Stay | 1 | 2014 | 317 | 0.030 |
Why?
|
| Perception | 1 | 2011 | 83 | 0.030 |
Why?
|
| Risk | 1 | 2011 | 217 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 301 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 298 | 0.020 |
Why?
|
| Memory | 1 | 2011 | 318 | 0.020 |
Why?
|
| Caregivers | 1 | 2011 | 143 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 11 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 22 | 0.020 |
Why?
|
| Health Education | 1 | 2005 | 39 | 0.020 |
Why?
|
| Leptin | 1 | 2005 | 22 | 0.020 |
Why?
|
| Ghrelin | 1 | 2004 | 3 | 0.020 |
Why?
|
| Triglycerides | 1 | 2005 | 41 | 0.020 |
Why?
|
| Body Size | 1 | 2004 | 11 | 0.020 |
Why?
|
| Body Composition | 1 | 2005 | 56 | 0.020 |
Why?
|
| Arylsulfotransferase | 1 | 2004 | 1 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 15 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2005 | 60 | 0.020 |
Why?
|
| Homeostasis | 1 | 2005 | 82 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 27 | 0.020 |
Why?
|
| Energy Intake | 1 | 2004 | 66 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 78 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 58 | 0.020 |
Why?
|
| New Mexico | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 4 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 37 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 76 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 340 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 770 | 0.010 |
Why?
|